Your browser doesn't support javascript.
loading
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Fassnacht, M; Assie, G; Baudin, E; Eisenhofer, G; de la Fouchardiere, C; Haak, H R; de Krijger, R; Porpiglia, F; Terzolo, M; Berruti, A.
Afiliação
  • Fassnacht M; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, Würzburg, Germany; Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.
  • Assie G; Department of Endocrinology, Reference Centre for Rare Adrenal Diseases, Reference Centre for Rare Adrenal Cancers, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, Paris, France; Institut Cochin, Institut National de la Santé et de la Recherche Médicale U1016, Centre National de la Recherche
  • Baudin E; Department of Endocrine Oncology and Nuclear Medicine, Gustave Roussy, Villejuif, France.
  • Eisenhofer G; Department of Medicine III and Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.
  • de la Fouchardiere C; Department of Medical Oncology, Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.
  • Haak HR; Department of Internal Medicine Máxima Medisch Centrum, Eindhoven, The Netherlands; Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands; Maastricht University, CAPHRI School for Public Health and Primary Care, Agei
  • de Krijger R; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Porpiglia F; Division of Urology, San Luigi Hospital - Orbassano, Turin, Italy; Department of Oncology, University of Turin, Turin, Italy.
  • Terzolo M; Internal Medicine, Department of Clinical and Biological Sciences, San Luigi Hospital, University of Turin, Turin, Italy.
  • Berruti A; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Medical Oncology, University of Brescia, ASST-Spedali Civili, Brescia, Italy.
Ann Oncol ; 31(11): 1476-1490, 2020 11.
Article em En | MEDLINE | ID: mdl-32861807

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feocromocitoma / Neoplasias do Córtex Suprarrenal / Neoplasias das Glândulas Suprarrenais / Carcinoma Adrenocortical Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feocromocitoma / Neoplasias do Córtex Suprarrenal / Neoplasias das Glândulas Suprarrenais / Carcinoma Adrenocortical Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha